格隆汇12月17日丨合富中国(603122.SH)在投资者互动平台表示,公司目前与浙江大学计算机创新技术研 究院深度合作创建临床诊疗AI辅助系统。 ...

证券日报网讯 12月17日，合富中国在互动平台回答投资者提问时表示，公司经营团队，始终以股东利 益为导向。公司积极关注行业内包括与赋能有关的新项目合作或投资以及其他进入业务空白省份等在内 的合作扩能机会，有任何机会公司专业团队会进行评估，也会请外部专业机构评估，如有相应计划，公 司将严格按照规定履行信息披露义务。 （编辑 任世碧） ...

证券日报网讯 12月17日，合富中国在互动平台回答投资者提问时表示，公司股东人数请详见公司披露 的定期报告。公司股东如有查询需求，请向公司提供其持有公司股份以及持股数量的书面证明文件（可 将有关证明文件发送至公司披露的电子邮箱：ir_cowealth@cowealth.com），公司经核实股东身份后将 为您提供相关数据。 （编辑 任世碧） ...

人民财讯12月12日电，2025年12月8日至2025年12月12日，上交所对146起拉抬打压、虚假申报等证券异 常交易行为采取了自律监管措施，对退市整理股票退市苏吴（600200），以及*ST亚振（603389）、合 富中国（603122）、天普股份（605255）等波动幅度较大的股票进行重点监控，对24起上市公司重大事 项等进行专项核查，向证监会上报涉嫌违法违规案件线索3起。 ...

格隆汇12月12日丨明基医院(02581.HK)发布公告，公司拟全球发售6700万股发售股份，中国香港发售股 份670万股，国际发售股份6030万股(以上可予重新分配)；2025年12月12日至12月17日招股，预期定价 日为12月18日；发售价将为每股发售股份9.34-11.68港元，H股的每手买卖单位将为500股，中金公司及 花旗为联席保荐人；预期股份将于2025年12月22日开始在联交所买卖。 集团借鉴中国台湾的医院运营管理经验，是中国内地一家民营营利性综合医院集团。集团目前拥有和运 营两家民营营利性综合医院。根据弗若斯特沙利文的数据，以2024年总收入计，集团是华东地区最大的 民营营利性综合医院集团，于华东地区的市场份额为1.0%；以相同口径计，集团在全国民营营利性综 合医院集团中排名第七，于中国的市场份额为0.4%；以2024年的床均收入计，集团在中国内地所有民 营营利性综合医院集团中排名第一。 集团已订立基石投资协议，据此，基石投资者已同意在若干条件的规限下按发售价认购或促使其指定实 体认购总金额3990万美元(或约3.11亿港元)可购买的有关数目的发售股份。假设发售价为10.51港元(即本 招股 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 【沐曦股份：网上投资者放弃认购20349股】 | | | 12月10日重要公告摘要 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 今日聚焦 | 信邦制药 | 公司涉嫌单位行贿被检察机关起诉 | | | 沐曦股份 | 网上投资者放弃认购20349股 | | | 永辉超市 | 门店调改稳步有序进行中 | | | 中央商场 | 授权公司管理层组织实施徐州店暂停营业计划 | | | 东百集团 | 第一大股东丰琪投资12月9日减持2.98%股份 | | | 蓝思科技 | 拟收购液冷和服务器机柜公司裴美高国际100%股权 | | | 宁德时代 | 拟注册发行不超过100亿元债券 | | | 贵州茅台 | 2025年中期分红300亿元 股权登记日为12月18日 | | | 五粮液 | 2025年中期分红100.07亿元 股权登记日为12月17日 | | | 世纪委通 | 子公司参股的国盛资本持有摩尔线程1958. 87万股 | | | 华谊兄弟 | 债务逾期5250万元 拟逐步退出和处置部分资产 | | | 西部材料 | 第二大股东西 ...

今日聚焦 1、贵州茅台：2025年中期分红300亿元 股权登记日为12月18日 贵州茅台(600519.SH)公告称，公司2025年中期利润分配方案已获股东大会通过，将以总股本12.52亿股 为基数，每股派发23.957元现金红利（含税），共计派发300.01亿元（含税）。股权登记日为2025年12 月18日，除权（息）日和现金红利发放日均为2025年12月19日。部分股东的红利将由公司自行发放。扣 税说明根据不同股东类型，分别按10%或20%税率代扣代缴所得税。 2、宁德时代：拟注册发行不超过100亿元债券 宁德时代(300750.SZ)12月10日公告，公司拟注册发行不超过100亿元（含100亿元）的债券，本次发行 的债券的期限不超过5年，主要用于项目建设、补充营运资金、偿还有息负债等。 3、3连板永辉超市：公司股票存在市场情绪过热情形及较高的炒作风险 3连板永辉超市(601933.SH)12月10日披露股票交易风险提示公告，经公司自查，截至目前，公司目前生 产经营活动正常，门店调改稳步有序进行中，内外部经营环境未发生重大变化，不存在应披露而未披露 的重大事项。鉴于近期公司股票交易价格涨幅较大，存在市场情 ...

Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]

New Stock Listings - Baiaosaitu (688796) listed at an issue price of 26.68 on December 10, 2025[1] - Quanyin Gaoke (300087) has a tender offer period from December 4, 2025, to January 5, 2026[1] - Tiangong Co. (605255) has a tender offer period from November 20, 2025, to December 19, 2025[1] Delisting and Trading Alerts - ST Guangdao (920680) enters the delisting arrangement period starting December 11, 2025[1] - ST Suwu (600200) has 13 trading days remaining until the last trading day[1] Market Volatility - Hai Xin Food (002702) reported severe abnormal fluctuations[1] - Anji Food (603696) and other companies are under observation for abnormal trading activities[2] Additional Announcements - Multiple companies including Dongbai Group (600693) and Nanjing Business Travel (600250) have recent announcements linked to their stock codes[1] - Various companies are linked to announcements regarding abnormal fluctuations and trading activities[3]

实达集团 | 301292 | 海科新源 | 65.65 | 29.33 | 1.17 | | --- | --- | --- | --- | --- | | 301584 | 建发致新 | 34.54 | 29.26 | 3.66 | | 002589 | 瑞康医药 | 3.90 | 29.08 | -7.58 | | 301183 | 东田微 | 175.88 | 28.78 | 8.24 | | 301232 | 飞沃科技 | 100.10 | 28.34 | 2.61 | | 603879 | 永悦科技 | 7.29 | 28.32 | 9.95 | | 301396 | 宏景科技 | 70.24 | 28.19 | -1.84 | | 301329 | 信音电子 | 24.88 | 27.96 | -2.12 | | 001386 | 马可波罗 | 24.82 | 27.91 | 10.02 | | 300421 | 力星股份 | 32.02 | 27.91 | 4.03 | | 003018 | 金富科技 | 20.16 | 27.85 | 6.11 | | 300056 | 中创环保 | 11. ...